{"nct_id":"NCT05458297","title":"A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-07-21","start_date_type":"ACTUAL","primary_completion_date":"2029-03-13","primary_completion_date_type":"ESTIMATED","completion_date":"2029-05-17","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}